AzTrials
AzTrials

AnxietyNCT05481203

The Effect Of Distraction Methods On Fear And Anxiety In Children Before The Covid 19 Test

A study testing The Kaleidescope and The visual illusion cards in people with Anxiety and Fear, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: This research will be carried out to determine the effect of distracting methods on fear and anxiety in children before the COVID test. Read more about this study

Who is it for?
Ages 5 to 10 yearsHealthy volunteers can take part
Conditions the study is for
Anxiety, Fear
What is being tested?
The Kaleidescope and The visual illusion cards
Could I receive a placebo?
No, everyone receives an active treatment
How many people
114 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2022to 1 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • children who will be taken samples for Covid 19 test
  • being between the ages of 5 to 10 years,
  • literate

Who cannot join

  • having chronic diseasesvisual
  • audio, or speech impairments
  • mental disorders,
  • history of sedative, analgesic, or narcotic use within 24 h before admission
  • inflammatory disease during admission.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ondokuz Mayis University

    Samsun, Atakum, 55250

Other trials in Turkey (Türkiye)

About this study

Aim: This research will be carried out to determine the effect of distracting methods on fear and anxiety in children before the COVID test.

Read the detailed description

Inroduction: In the literature review, it has been seen that the positive effect of different nanpharmacological methods is supported to reduce pain and anxiety caused by medical procedures. Non-pharmacological methods are classified as physical methods, cognitive behavioral methods, and environmental or emotional intervention methods. In order to draw attention to another direction, which is among these methods; watching cartoons, inflating balloons, creating balloons by blowing foam, talking about things unrelated to the initiative, virtual reality glasses, listening to music, using kaleidoscope and distraction cards etc. is located. The subject of the study is the application of distraction methods in reducing the pain associated with short-term medical interventions.

Conditions
Anxiety, Fear
Being tested
The Kaleidescope, The visual illusion cards
Keywords
COVID-19 test, nasopharyngeal swab collection, pediatric nursing, distraction methods
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The KaleidescopeBehavioural

    During the nasopharyngeal swab collection process, the researcher held a kaleidoscope to each child's eye, leisurely turning it and asking about the colors and shapes seen within it.

  • The visual illusion cardsBehavioural

    Just before the nasopharyngeal swab participants were allowed to check the cards andwere askedwhat they saw in them.

Study groups in NCT05481203
Study groupRoleWhat they receive
The Kaleidescope GroupExperimentalKaleidoscope Group: it and asking about the colors and shapes seen within it. This distraction procedure started before the procedure and continued until it ended.
Receives: Behavioral: The Kaleidescope
The Visual Illusion Cards GroupExperimentalThe Visual Illusion Cards Group: Just before the nasopharyngeal swab participants were allowed to check the cards and were asked what they saw in them.
Receives: Behavioral: The visual illusion cards
The Control GroupNo interventionThe control group received the routine nasopharyngeal swab procedure and did not receive any other nonpharmacological intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. changing the anxiety in the Kaleidoscope group

    changing the anxiety scores of the children in the Kaleidoscope group during Covid 19 test

    Measured: up to 6 months

  2. changing the fear in the Kaleidoscope group

    changing the fear scores of the children in the Kaleidoscope group during Covid 19 test

    Measured: up to 6 months

  3. changing the anxiety in the Visual Illusion Cards group

    changing the anxiety scores of the children in the Visual Illusion Cards group during Covid 19 test

    Measured: up to 6 months

  4. changing the fear in the Visual Illusion Cards group

    changing thefear scores of the children in the Visual Illusion Cards group during Covid 19 test

    Measured: up to 6 months

Secondary outcomes (2)
  1. changing the "Child Anxiety Scale-Stateness" score

    The Children's Anxiety Meter (CAM) used. It assesses children's anxiety in clinical settings and uses before medical procedures. The CAM is drawn like a thermometer with a bulb at the bottom, also includes horizontal lines at intervals going up to the top. Children are asked to mark how he/she feel "right now" to measure state anxiety. Scores range from 0 to 10.

    Measured: up to 6 months

  2. changing the "Child Fear Scale" score

    The Child Fear Scale (CFS) used. This one-item scale consists of five sex-neutral faces. It ranges from a no fear (neutral) face on the far left to a face showing extreme fear on the far right. The rater responds indicates the level of fear. Scores range from 0 to 4.

    Measured: up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2022
  2. Study start1 Mar 2022
  3. Primary completion1 Jun 2022
  4. Study completion1 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This was an RCT with parallel groups conducted between March, 2022 and August, 2022 at the pediatric emergency unit of a hospital in Black Sea Region Turkey
Masking
None (open label)
Enrolment
114 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05481203
Sponsor's protocol ID
Distraction
Status last verified
Jul 2022
First submitted
28 Jul 2022
Last updated
1 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing The Kaleidescope and The visual illusion cards in people with Anxiety and Fear, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

changing the anxiety in the Kaleidoscope group (time frame: up to 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in